2A Pharma ApS Financials, key figures and credit report
Gross profit 587.3 kDKK FY 2025 -0.7% vs 2024
EBIT - 834.0 kDKK FY 2025 -455.5% vs 2024
Net debt -75.2 kDKK FY 2025 -185.1% vs 2024
Quick ratio 6.6 FY 2025 +6.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 948.30 | - 210.11 | 159.25 | 591.32 | 587.25 |
| Employee benefit expenses | -1 577.59 | -1 297.31 | - 262.70 | - 741.47 | -0.35 |
| Total depreciation | -8.33 | -8.33 | -5.23 | -1 420.94 | |
| EBIT | 362.38 | -1 515.75 | - 108.68 | - 150.16 | - 834.04 |
| Other financial income | 0.95 | 0.17 | 121.37 | ||
| Other financial expenses | -10.18 | -8.40 | -0.02 | -2.66 | |
| Pre-tax profit | 353.16 | -1 523.98 | - 108.71 | - 152.82 | - 712.67 |
| Income taxes | -81.46 | 66.09 | 157.11 | ||
| Net earnings | 271.69 | -1 523.98 | -42.62 | 4.30 | - 712.67 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Development expenditure | 300.16 | 1 420.94 | |||
| Intangible assets total | 300.16 | 1 420.94 | |||
| Machinery and equipment | 13.56 | 5.23 | |||
| Tangible assets total | 13.56 | 5.23 | |||
| Investments total | 26.73 | 26.73 | 8.91 | 8.91 | 8.91 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 9.82 | ||||
| Current amounts owed by group member comp. | 726.02 | 192.30 | |||
| Current other receivables | 530.57 | 26.26 | 115.72 | 32.65 | |
| Current deferred tax assets | 8.00 | 66.03 | 157.11 | ||
| Short term receivables total | 726.02 | 548.38 | 92.30 | 272.83 | 224.95 |
| Cash and bank deposits | 557.03 | 728.68 | 433.06 | 28.79 | 75.22 |
| Cash and cash equivalents | 557.03 | 728.68 | 433.06 | 28.79 | 75.22 |
| Balance sheet total (assets) | 1 323.34 | 1 309.03 | 834.43 | 1 731.47 | 309.07 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Other reserves | 216.11 | 1 108.33 | 1 108.33 | ||
| Retained earnings | 616.78 | 888.47 | 448.38 | - 186.47 | - 182.17 |
| Profit of the financial year | 271.69 | -1 523.98 | -42.62 | 4.30 | - 712.67 |
| Shareholders equity total | 938.47 | - 585.51 | 671.87 | 976.16 | 263.49 |
| Non-current liabilities total | |||||
| Current trade creditors | 250.66 | 1 798.56 | 120.50 | 72.72 | 45.00 |
| Current owed to group member | 80.15 | 2.40 | |||
| Short-term deferred tax liabilities | 81.46 | ||||
| Other non-interest bearing current liabilities | 52.74 | 15.83 | 42.06 | 31.07 | 0.58 |
| Accruals and deferred income | 649.11 | ||||
| Current liabilities total | 384.87 | 1 894.54 | 162.56 | 755.31 | 45.59 |
| Balance sheet total (liabilities) | 1 323.34 | 1 309.03 | 834.43 | 1 731.47 | 309.07 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated